After the FDA revoked its approval of Avastin for the treatment of metastatic breast cancer, the drug maker says it will initiate new trials.
The Scientist
Most Recent
New congressional proposals would allow drug makers to bypass traditional clinical trial requirements for drugs that address rare diseases.
The US regulatory agency recalled 54 percent more drugs from the second to third quarters of 2011.
The NIH, FDA, and DARPA are teaming up to develop a chip to test drug toxicities as one of the first projects of the NIH's new translational research center.
The US government agency vows to improve the way it facilitates the development and approval of drugs for orphan diseases.
The US federal agency issues draft rules to guide medical device makers and those hoping to register biomarkers.
The social media site enforces its rule that pages should allow social interaction through comments, even on drug company pages.
Blood tests can accurately determine a fetus’s gender as early as 7 weeks.
The government says regulatory requirements for generic biological therapies will have to be tailored to the treatment in question.
The bill to raise the debt ceiling and reduce the deficit would slash billions of dollars for basic scientific and medical research.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
